Collagenase inhibitors (penicillamine).
D000328:Adult; D000468:Alkalies; D000818:Animals; D001120:Arginine / Q000494:pharmacology; D001414:Bacitracin / Q000627:therapeutic use; D002057:Burns, Chemical / Q000201:enzymology*; D002921:Cicatrix; D003263:Contact Lenses, Hydrophilic; D003315:Cornea / Q000201:enzymology; D003320:Corneal Ulcer / Q000188:drug therapy*; D003538:Cystamine / Q000627:therapeutic use; D003545:Cysteine / Q000627:therapeutic use; D003553:Cystine / Q000627:therapeutic use; D004492:Edetic Acid / Q000627:therapeutic use; D005126:Eye Burns / Q000201:enzymology*; D005260:Female; D005347:Fibroblasts / Q000201:enzymology; D005978:Glutathione / Q000627:therapeutic use; D006801:Humans; D007962:Leukocytes / Q000201:enzymology; D008278:Magnesium Sulfate / Q000627:therapeutic use; D008297:Male; D008722:Methods; D003012:Microbial Collagenase / Q000037:antagonists & inhibitors*; D008875:Middle Aged; D010396:Penicillamine / Q000627:therapeutic use*; D011817:Rabbits; D013054:Spectrophotometry, Atomic
D000468:Alkalies; D001414:Bacitracin; D003553:Cystine; D008278:Magnesium Sulfate; D001120:Arginine; D004492:Edetic Acid; D003012:Microbial Collagenase; D005978:Glutathione; D010396:Penicillamine; D003545:Cysteine; D003538:Cystamine